Compare JBSS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBSS | CBLL |
|---|---|---|
| Founded | 1959 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 801.2M | 935.3M |
| IPO Year | 1994 | 2024 |
| Metric | JBSS | CBLL |
|---|---|---|
| Price | $68.51 | $23.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $100.00 | $28.57 |
| AVG Volume (30 Days) | 88.0K | ★ 281.8K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 6.58% | N/A |
| EPS Growth | 4.57 | ★ 56.93 |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $1,175,673,000.00 | $89,063,000.00 |
| Revenue This Year | $2.04 | $29.66 |
| Revenue Next Year | $3.12 | $27.36 |
| P/E Ratio | $13.00 | ★ N/A |
| Revenue Growth | 6.18 | ★ 36.09 |
| 52 Week Low | $59.07 | $10.85 |
| 52 Week High | $92.08 | $25.63 |
| Indicator | JBSS | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 45.58 |
| Support Level | N/A | $23.07 |
| Resistance Level | $84.75 | $25.12 |
| Average True Range (ATR) | 1.45 | 0.88 |
| MACD | 0.55 | -0.20 |
| Stochastic Oscillator | 77.89 | 23.61 |
John B Sanfilippo & Son Inc is processors and distributors of peanuts, pecans, cashews, walnuts, almonds and other nuts in the United States. It also manufacture and distribute a portfolio of snack and nutrition bars, and market and distribute, and in some cases, manufacture or process, a diverse product line of other food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snack and trail mixes, granola, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products. It mainly sell its products under a variety of private brand names, as well as under its Fisher, Orchard Valley Harvest, Squirrel Brand and Southern Style Nuts brand names. It operate in a single reporting segment.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.